The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells

Abstract

Tumor necrosis factor (TNF) is a pleiotropic cytokine that has both pro-inflammatory and anti-inflammatory functions. The biological functions of TNF are mediated by two receptors, TNF receptor type I (TNFR1) and TNF receptor type II (TNFR2). TNFR1 is expressed universally on almost all cell types and has been extensively studied, whereas TNFR2 is mainly restricted to immune cells and some tumor cells and its role is far from clarified. Studies have shown that TNFR2 mediates the stimulatory activity of TNF on CD4+Foxp3+ regulatory T cells (Tregs) and CD8+Foxp3+ Tregs, and is involved in the phenotypic stability, proliferation, activation, and suppressive activity of Tregs. TNFR2 can also be expressed on CD8+ effector T cells (Teffs), which delivers an activation signal and cytotoxic ability to CD8+ Teffs during the early immune response, as well as an apoptosis signal to terminate the immune response. TNFR2-induced abolition of TNF receptor-associated factor 2 (TRAF2) degradation may play an important role in these processes. Consequently, due to the distribution of TNFR2 and its pleiotropic effects, TNFR2 appears to be critical to keeping the balance between Tregs and Teffs, and may be an efficient therapeutic target for tumor and autoimmune diseases. In this review, we summarize the biological functions of TNFR2 expressed on CD8+Foxp3+ Tregs and CD8+ Teffs, and highlight how TNF uses TNFR2 to coordinate the complex events that ultimately lead to efficient CD8+ T cell-mediated immune responses.

Tumor Necrosis Factor-Alpha Inhibitory Therapy for Non-Infectious Autoimmune Uveitis

“…TNFR2, also known as p75, is preferentially expressed on endothelial and hematopoietic cells, and some tumor cells. The subsequent pathways at this time are not as well delineated as those for TNFR1, but ongoing studies suggest TNFR2 mediates the activity of regulatory and effector CD8+ T cells, as well as interleukin production by B cells [3,4]. In the eye, pigment epithelial cells of the iris, the ciliary body, and retina locally express TNFR1 and TNFR2.…”

A network analysis to identify pathophysiological pathways distinguishing ischaemic from non‐ischaemic heart failure

“…All of these proteins are involved in the regulation of inflammatory pathways. TNFRSF1B is implicated in T‐cell‐mediated immune responses . MMP3 is an important downstream activator of MMPs, including MMP9 which is implicated in the cleavage of ITGB2 leading to exodus of macrophages from the area of inflammation, which is vital in limiting the local innate immune response .…”

Multipanel mass cytometry reveals anti–PD-1 therapy–mediated B and T cell compartment remodeling in tumor-draining lymph nodes

“…Interestingly, our high-parameter analysis also revealed a Treg subset producing increased TNF-α and NKT cells producing increased IL-2 in response to anti-PD-1 therapy. The role of TNF-α as an antitumor molecule and a stimulator of adaptive immunity is well established (22)(23)(24)(25). Recent studies, however, have demonstrated that Tregs are maintained by TNF-α via TNF receptor 2 (26) and themselves produce TNF-α in response to activation, providing an autocrine immune-suppressive effect (27).…”